Esophageal capsule endoscopy (ECE) is considered to be an alternative to conventional
esophagogastroduodenoscopy (EGD); however, its indications continue to expand. This
report presents results from the use of ECE in patients with hemophilia at a tertiary
referral academic center over a 7-year period. A total of 16 patients with hemophilia,
who were all at risk of new-variant Creutzfeldt-Jakob disease due to previous treatment
with UK plasma-derived pooled blood products, underwent a total of 28 ECE examinations.
Main outcomes were the diagnostic yield of ECE, requirement for subsequent conventional
EGD, and any variceal bleeding episodes during the follow-up period. The overall diagnostic
yield was 67.8 % (19 /28 ECEs). Only one patient underwent conventional EGD, for esophageal
biopsies. There were no variceal hemorrhage events in any of the patients on variceal
screening follow-up. ECE is a useful and acceptable alternative to conventional endoscopy
in selected patient groups (i. e. patients with hemophilia). In this group, ECE can
eliminate the need for prior administration of clotting factors.